免疫抑制と抗ウイルス療法に対するヒトウイルスの時間的反応
Iwijn De Vlaminck1, Kiran K Khush, Calvin Strehl
1Departmets of Bioengineering and Applied Physics, Stanford University and the Howard Hughes Medical Institute, Stanford, CA 94305, USA.
Cell
|November 26, 2013
まとめ
免疫抑制剤と抗ウイルス薬は,臓器移植受容者のヒトウイルス群を大幅に変化させます. この研究は,これらの治療がウイルス負荷と組成にどのように影響するかを明らかにし,免疫システムの健康に関する洞察を提供します.
科学分野:
- 免疫学 免疫学とは
- ウイルス学 ウイルス学 ウイルス学
- マイクロバイオームの研究
背景:
- 免疫系の健康を測定することは難しい.
- 免疫力と微生物群のウイルス成分 (ウイルス群) の関連性は不明である.
- 臓器移植受容者は,免疫抑制および抗ウイルス療法により,ユニークなモデルを提供しています.
研究 の 目的:
- 免疫抑制薬と抗ウイルス薬が臓器移植受容者のプラズマウイルスにどのように影響するか調査する.
- 薬-ウイルス相互作用のダイナミクスを理解するために.
- 免疫能力のバイオマーカーとしてのウィロームの可能性を調査する.
主な方法:
- 血中の細胞フリーDNAの配列決定.
- 臓器移植を受けた96人のサンプル (656サンプル) の分析.
- 薬-ウイルス相互作用とウイルス組成の調査.
主要な成果:
- 抗ウイルス薬および免疫抑制薬は,プラズマウイルス構造を大幅に変化させます.
- ウイルスの負荷は免疫抑制によって増加しますが,細菌の微生物群は影響を受けません.
- 治療開始時に観察されたウイルス組成の顕著な変化.
結論:
- 薬理学的治療は,ヒトのウイルス群に深い影響を及ぼします.
- ウイルスの状態は,免疫システムの調節と薬物効果を反映しています.
- 血ウイルス群分析は,患者の免疫能力の予測に役立ちます.
関連する概念動画
Human Virome
54
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible...
54
Immune Response Against Viral Pathogens
2.4K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.4K
Inhibitors of Viral Protein Synthesis
73
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
73
Viral Mutations
33.2K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
33.2K
Size and Structure of Viral Genomes
1.2K
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
1.2K


